Table 2. The GIRISH framework: six steps for safe, effective AI use at the NICU bedside.
BNFc: British National Formulary for Children; BPD: bronchopulmonary dysplasia; BW: Birth weight; CRP: C-reactive protein; DOB: Date of birth; DOL: Day of life; FiO2: Fraction of inspired oxygen; GA: Gestational age; GIRISH: Goal, Input, Role, Iterative refinement, Safety verification, and Human accountability; LLM: Large language model; MRN: Medical record number; PMA: Post-menstrual age; WBC: White blood cell count.
| Step | What you do | Illustrative prompt | Clinical safety note |
| G – Goal | Define one bounded clinical task per interaction – a single, answerable question rather than “help me with this baby.” | “Generate a ranked differential for clinical deterioration in a 28-week infant, DOL 7, rising FiO2, CRP 48.” | One interaction, one goal. Broad, open-ended prompts return broad, unverifiable answers. |
| I – Input | Provide structured clinical context and anonymize rigorously before entering anything. | GA 28w, BW 950 g, DOL 7, FiO2 0.55 (was 0.38), CRP 48, WBC 18.4, temp 37.9℃, on ampicillin day 7. No name, DOB, or MRN. | Never enter identifiers into any LLM. In small NICUs, GA, BW, and DOL together may re-identify a patient – state what is unavailable (e.g., “echo not yet done”) rather than omit it. |
| R – Role | Tell the AI what role it is playing and explicitly limit its scope. | “Act as a neonatal evidence-retrieval assistant. Generate differentials and suggest investigations. Do not prescribe. Flag uncertainty and an evidence grade for every suggestion.” | Explicitly limiting the role reduces hallucination risk. An AI instructed not to prescribe is less likely to volunteer an uncaveated drug dose. |
| I – Iterative refinement | Do not accept the first response; interrogate it, and follow up with specific challenges. | After the AI ranks late-onset sepsis first, ask: “Can BPD be diagnosed at DOL 7?” It corrects itself: not applicable until 36 weeks PMA. Then ask for the evidence grade for adding Gram-negative cover. | If output contradicts clinical gestalt, do not default to the AI. Ask it to cite its source and state what it is uncertain about. Disagreement is information. |
| S – Safety verification | Verify every drug dose, antibiotic, and threshold against your formulary and unit protocol before acting. | Verify gentamicin dose (GA-specific, Neofax/BNFc). Check the local antibiogram for Gram-negative cover. Review the record for contraindications. | Hallucination red flags: a dose outside the GA-expected range; a guideline attributed to a non-existent or outdated source; internal inconsistency (e.g., ibuprofen despite documented oliguria); overconfident probability language without an evidence grade. |
| H – Human accountability | Document that a named clinician made the decision. The AI assisted; the clinician decided. | Record: “AI-assisted differential generation, GIRISH framework, [date]. Platform: [name]. Output verified against [formulary/guideline]. Decision by [Name], [Designation], [Time].” | In multidisciplinary settings, designate a GIRISH interaction lead. The AI has no accountability; the clinician does. Documentation should follow local institutional and medico-legal policy: as consumer LLMs are not approved medical devices, units should record AI assistance in line with their own information-governance and AI-use policies rather than adopting fixed wording uncritically (see “Regulatory context”). |